close

Enter

Log in using OpenID

Injectable Nanomedicines Market Global Trends, Market Share, Industry Size, Growth, Opportunities, and Market Forecast 2019 to 2029

embed
Global injectable nanomedicines market to value over USD 400 Million by 2029 end and register a CAGR of over 8% from 2019 to 2029. Substantial research and advancements in technology for drug development have given a significant boost in the global
Injectable Nanomedicines Market Global Trends, Market Share, Industry Size,
Growth, Opportunities, and Market Forecast 2019 to 2029
Global injectable nanomedicines market to value over USD 400 Million by 2029 end
and register a CAGR of over 8% from 2019 to 2029.
Substantial research and advancements in technology for drug development have
given a significant boost in the global injectable nanomedicines market. Globally, the
increase in use of liposomal drugs and growing patient population has fueled
demand for injectable nanomedicines. Developing application of nanomedicines in
the medical sector and therapeutics is further augmenting the demand of the global
market.
With selective drug delivery and target specific drug therapies are crucial factors for
the substantial growth of the market. Due to the rising demand for regenerative
medicines, and research for the same has further augmented demand for injectable
nanomedicines. Additionally, increased casualties due to cancer has increased
growth opportunity in the global market. The increasing availability of cheaper
generics in both developing and developed markets retrains the market’s growth.
North America is projected to lead the global injectable nanomedicines market in the
foreseeable future. The higher resource engaged in drug research and development
is speculated to boost demand. The market in Europe and Asia is also estimated to
grow at a considerable CAGR.
Significant firms in the market are Pfizer Inc., Merck & Co, Inc., Lupin, Janssen
Biotech Inc., Hoffmann-La Roche Ltd., Amgen Inc., Teva Pharmaceutical Industries
Ltd., Pacira Pharmaceuticals Inc., Celgene Corporation and Bausch & Lomb
Incorporated, among others. Strategies of mergers, fast drug approvals and
acquisitions are popular in order to gain traction.
Request a Sample Report @ https://www.futurewiseresearch.com/requestsample.aspx?id=257&page=requestsample
Global Injectable Nanomedicines Market Segmentation
By Drug Type
● Liposomes
● Micelles
● Nanocrystals
● Polymeric Nanoparticles
● Metallic Nanoparticles
● Mesoporous Silica Nanoparticles
● Others
By Application
● Cancers
● Central Nervous System Diseases
● Cardiovascular diseases
● Infection Control
● Inflammatory Diseases
● Others
By End User
● Hospitals
● Ambulatory Surgical Centers
● Clinics
● Specialized Drugs R&D Institutes
● Managed Care Organizations
By Region:
● Europe
● North America
● APAC
● Latin America
● Rest of World
Purchase a Copy & Ask For Discount: https://www.futurewiseresearch.com/requestsample.aspx?id=257&page=askfordiscount
Competitive Landscape:
● Tier 1 players- established companies in the market with a major market share
● Tier 2 players
● Emerging players which are growing rapidly
● New Entrants
FutureWise Key Takeaways
● Growth prospects
● SWOT analysis
● Key trends
● Key data points affecting market growth
Objectives of the Study:
● To provide an exhaustive analysis on injectable nanomedicines by drug type, by
application and region
● To cater comprehensive information on factors impacting market growth
(drivers, restraints, opportunities, and industry-specific restraints)
● To evaluate and forecast micro-markets and overall market
● To predict the market size, in key regions (along with countries)—North America,
Europe, Asia Pacific, Latin America, and the Middle East and Africa
● To record evaluate and competitive landscape mapping- product launches,
technological advancements, mergers and expansions
● Profiling of companies to evaluate their market shares, strategies, financials and
core competencies
Table of Contents
1. Market Introduction
1.1. Market Taxonomy
1.2. Market Definition
2. Executive Summary
2.1. Market Overview
2.2. Market Analysis
3. Market Dynamics
3.1.1. Drivers
3.1.2. Restraints
3.1.3. Trends
4. Key Inclusions
4.1. Nanomedicines Development Over Time
4.2. Regulatory Scenario
4.3. Disease Epidemiology
4.4. Approvals of Commercial Injectable Nanomedicines
5. Injectable nanomedicines Market Value (US$ Mn) Analysis By Drug Type



Liposomes
Micelles
Nanocrystals




Polymeric Nanoparticles
Metallic Nanoparticles
Mesoporous Silica Nanoparticles
Others
6. Injectable nanomedicines Market Value (US$ Mn) Analysis By Application






Cancers
Central Nervous System Diseases
Cardiovascular diseases
Infection Control
Inflammatory Diseases
Others
7. Injectable nanomedicines Market Size (US$ Mn) Analysis By End User





Hospitals
Ambulatory Surgical Centers
Clinics
Specialized Drugs R&D Institutes
Managed Care Organizations
8. North America Injectable Nanomedicines Market Analysis 2014–2018 and Forecast
2019–2029
8.1. Introduction
8.2. Historical Market Size (US$ Mn) Trend Analysis By Country, 2014–2018
8.2.1. U.S.
8.2.2. Canada
9. Latin America Injectable Nanomedicines Market Analysis 2014–2018 and Forecast
2019–2029
9.1. Introduction
9.2. Historical Market Size (US$ Mn) Trend Analysis By Country, 2014–2018
9.2.1. Brazil
9.2.2. Mexico
9.2.3. Rest of Latin America
8. Europe Injectable Nanomedicines Market Analysis 2014–2018 and Forecast 2019–
2029
8.1. Introduction
8.2. Historical Market Size (US$ Mn) Trend Analysis By Country, 2014–2018
8.2.1. Germany
8.2.2. U.K.
8.2.3. France
8.2.4. Italy
8.2.5. Spain
8.2.6. Russia
8.2.7. Rest of Europe
8.10.2. By Drug Type
8.10.3. By Application
8.10.4. By End User
9. Asia Pacific Injectable Nanomedicines Market Analysis 2014–2018 and Forecast
2019–2029
9.1. Introduction
9.2. Historical Market Size (US$ Mn) Trend Analysis By Country, 2014–2018
9.2.1. Japan
9.2.2. China
9.2.3. India
9.2.4. Australia and New Zealand
9.2.5. Rest of Asia Pacific
10. Middle East & Africa Injectable Nanomedicines Market Analysis 2014–2018 and
Forecast 2019–2029
10.1. Introduction
10.2. Historical Market Size (US$ Mn) Trend Analysis By Country, 2014–2018
10.2.1. GCC Countries
10.2.2. South Africa
10.2.3. Rest of MEA
11. Competition Analysis










Merck & Co., Inc.
Lupin
Pacira Pharmaceuticals Inc.
Celgene Pharmaceutical Co. Ltd.
Amgen, Inc.
Janssen Biotech Inc. (Sub. Johnson & Johnson Services, Inc.)
Pfizer Inc.
Hoffmann-La Roche Ltd.
Teva Pharmaceutical Industries Ltd.
Bausch & Lomb Incorporated.
Inquire further details about this report at: [email protected]
About FutureWise Research:
We specialise in high-growth niche markets, assuring flexibility, agility and
customised solutions for our clients. Through in-depth market insights and
consultancy, we present our clients with the tools they need to be at the forefront of
their industry – a position secured for far more than the near future.
Contact Us:
Company Name: FutureWise Research
Contact Person: Vinay Thaploo
Email: [email protected]
Phone: +44 141 628 9353 / +1 970 279 4295
City: Leeds
Country: United Kingdom
Website: www.futurewiseresearch.com
1/--pages
Report inappropriate content